Synmosa Group Subsidiary Ningbo Youhe Awarded GSP Certification

Date:2016.01.06

Synmosa Biopharma (TPEx:4114) today announced that it has achieved record-breaking revenue growth in the mainland China market. In addition, Ningbo Youhe Medicine Co., Ltd., a subsidiary of the Synmosa Group, is now officially certified to meet China's newly-revised GSP (Good Supply Practice) standards for pharmaceutical products, clearing the way for further expansion of the company's sales network in mainland China. After being certified to comply with China's GSP standards, and with applications for numerous other import drug licenses (IDLs) already in the pipeline, it is anticipated that multiple pharmaceutical products, such as Actein®, will be approved for registration in China in 2016 or continue to the next phase of the drug approval process. As a result of these new breakthroughs, the Synmosa Group anticipates that the mainland China market will be a strong engine for further revenue growth in the near future.